- Home
- CYTK vs COLB Comparison
CYTK vs COLB Comparison
Compare CYTK & COLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYTK
- COLB
- Stock Information
- Founded
- CYTK 1997
- COLB 1993
- Country
- CYTK United States
- COLB United States
- Employees
- CYTK N/A
- COLB N/A
- Industry
- CYTK Biotechnology: Pharmaceutical Preparations
- COLB Major Banks
- Sector
- CYTK Health Care
- COLB Finance
- Exchange
- CYTK Nasdaq
- COLB Nasdaq
- Market Cap
- CYTK 5.7B
- COLB 5.9B
- IPO Year
- CYTK 2004
- COLB N/A
- Fundamental
- Price
- CYTK $45.82
- COLB $28.84
- Analyst Decision
- CYTK Buy
- COLB Hold
- Analyst Count
- CYTK 15
- COLB 15
- Target Price
- CYTK $83.64
- COLB $28.70
- AVG Volume (30 Days)
- CYTK 1.1M
- COLB 1.5M
- Earning Date
- CYTK 02-25-2025
- COLB 01-23-2025
- Dividend Yield
- CYTK N/A
- COLB 5.02%
- EPS Growth
- CYTK N/A
- COLB 20.93
- EPS
- CYTK N/A
- COLB 2.32
- Revenue
- CYTK $3,219,000.00
- COLB $1,828,770,000.00
- Revenue This Year
- CYTK N/A
- COLB N/A
- Revenue Next Year
- CYTK $710.83
- COLB $3.14
- P/E Ratio
- CYTK N/A
- COLB $12.43
- Revenue Growth
- CYTK N/A
- COLB 12.40
- 52 Week Low
- CYTK $44.49
- COLB $17.08
- 52 Week High
- CYTK $84.92
- COLB $32.85
- Technical
- Relative Strength Index (RSI)
- CYTK 39.27
- COLB 57.15
- Support Level
- CYTK $44.49
- COLB $27.81
- Resistance Level
- CYTK $48.45
- COLB $29.18
- Average True Range (ATR)
- CYTK 1.65
- COLB 0.73
- MACD
- CYTK -0.08
- COLB 0.29
- Stochastic Oscillator
- CYTK 23.50
- COLB 89.67
About CYTK Cytokinetics Incorporated
Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.
About COLB Columbia Banking System Inc.
Columbia Banking System Inc is a registered bank holding company whose wholly-owned banking subsidiary is Columbia State Bank. The company provides a full range of banking services to small and medium sized businesses, professionals, and individuals throughout Washington, Oregon, Idaho, and California. The company's subsidiary Columbia Trust Company is an Oregon trust company that provides agency, fiduciary, and other related trust services with offices in Washington, Oregon, and Idaho. The firm offers various products and services under Personal Banking, Business Banking, and Wealth Management divisions.